Stocks News

LAST PRICE
244.7500
TODAY'S CHANGE (%)
Trending Down-2.0500 (-0.8306%)

Bid / Lots
244.5600/ 7
Ask / Lots
245.0400/ 7
Open / Previous Close
248.9000 / 246.8000
Day Range
Low 244.6250
High 248.9000
52 Week Range
Low 141.9750
High 304.3900
Volume
181,215
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 18, 2024
- DJ Alnylam Pharmaceuticals Price Target Maintained With a $296.00/Share by Piper Sandler, from 1:10PM ET on Monday Nov 18, 2024 by Dow Jones
  1:10PM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: ALNY
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ALNY/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 18, 2024 13:10 ET (18:10 GMT)
- DJ Alnylam Pharmaceuticals Price Target Maintained With a $400.00/Share by HC Wainwright & Co., from 12:59PM ET on Monday Nov 18, 2024 by Dow Jones
  12:59PM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: ALNY
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ALNY/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 18, 2024 12:59 ET (17:59 GMT)
- Alnylam Pharmaceuticals Says Nucresiran Performed Well in Phase 1 Transthyretin Amyloidosis Study, from 3:42AM ET on Monday Nov 18, 2024 by MT Newswires
  3:42AM ET on Monday Nov 18, 2024 by MT Newswires
  Companies Mentioned: ALNY
  03:42 AM EST, 11/18/2024 (MT Newswires) -- Alnylam Pharmaceuticals (ALNY) said Sunday its phase 1 study of nucresiran as a potential treatment for transthyretin amyloidosis showed the drug's efficacy. Transthyretin amyloidosis is a condition charact...
Nov 17, 2024
- Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04) Showing Rapid Knockdown of TTR that is Sustained at Six Months Following a Single Dose, from 9:30AM ET on Sunday Nov 17, 2024 by Dow Jones
  9:30AM ET on Sunday Nov 17, 2024 by Dow Jones
  Companies Mentioned: ALNY
  
  relied upon as representing its views as of any subsequent date. Alnylam explicitly disclaims any obligation, except to the extent required by law, to update any forward-looking statements.
Nov 12, 2024
- Alnylam Pharmaceuticals Shares Fall After Wolfe Downgrade, from 2:23PM ET on Tuesday Nov 12, 2024 by MT Newswires
  2:23PM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: ALNY
  02:23 PM EST, 11/12/2024 (MT Newswires) -- Alnylam Pharmaceuticals (ALNY) shares were down more than 3% in recent Tuesday trading after Wolfe downgraded the stock to underperform from peer perform. Trading volume stood at about 505,000 shares agains...

Today
- DJ Novo Nordisk A/S Stock Rises Friday, Outperforms Market, from 2 hours ago by Dow Jones
  2 hours ago by Dow Jones
  Companies Mentioned: NVO
Yesterday
- DJ The FDA Can't Decide Whether Zepbound Is in Shortage. It's Good News for Hims & Hers. -- Barrons.com, from 21 hours ago by Dow Jones
  21 hours ago by Dow Jones
  Companies Mentioned: LLY, NVO
- Prestige Consumer Healthcare Insider Sold Shares Worth $898,241, According to a Recent SEC Filing, from 22 hours ago by MT Newswires
  22 hours ago by MT Newswires
  Companies Mentioned: PBH
- DJ Novo Nordisk A/S Stock Falls Thursday, Underperforms Market, from 12:03PM ET on Thursday Nov 21, 2024 by Dow Jones
  12:03PM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: NVO
- European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday, from 11:20AM ET on Thursday Nov 21, 2024 by MT Newswires
  11:20AM ET on Thursday Nov 21, 2024 by MT Newswires
  Companies Mentioned: NOK, NVO, EQNR, GRFS, DAVA, BNTX, CMPS, SLN, SHEL
- DJ Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barrons.com, from 2:00AM ET on Thursday Nov 21, 2024 by Dow Jones
  2:00AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: LLY, NVO, AMGN
Nov 20, 2024
- DJ Novo Nordisk A/S Stock Rises Wednesday, Outperforms Market, from 12:03PM ET on Wednesday Nov 20, 2024 by Dow Jones
  12:03PM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: NVO
- Sector Update: Health Care Stocks Edge Higher Premarket Wednesday, from 9:18AM ET on Wednesday Nov 20, 2024 by MT Newswires
  9:18AM ET on Wednesday Nov 20, 2024 by MT Newswires
  Companies Mentioned: IBB, NVO, XLV, ARGX, SAGE
- John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX® (collagenase clostridium histolyticum), from 8:50AM ET on Wednesday Nov 20, 2024 by CNW Group
  8:50AM ET on Wednesday Nov 20, 2024 by CNW Group
  Companies Mentioned: NDOI
- John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX(R) (collagenase clostridium histolyticum), from 8:50AM ET on Wednesday Nov 20, 2024 by PR Newswire
  8:50AM ET on Wednesday Nov 20, 2024 by PR Newswire
  Companies Mentioned: NDOI

Alnylam Pharmaceuticals Inc
NASDAQ:ALNYUnited States

Search Criteria

Nov 18, 2024

DJ Alnylam Pharmaceuticals Price Target Maintained With a $296.00/Share by Piper Sandler, from 1:10PM ET on Monday Nov 18, 2024 by Dow Jones

DJ Alnylam Pharmaceuticals Price Target Maintained With a $400.00/Share by HC Wainwright & Co., from 12:59PM ET on Monday Nov 18, 2024 by Dow Jones

Alnylam Pharmaceuticals Says Nucresiran Performed Well in Phase 1 Transthyretin Amyloidosis Study, from 3:42AM ET on Monday Nov 18, 2024 by MT Newswires

Nov 17, 2024

Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04) Showing Rapid Knockdown of TTR that is Sustained at Six Months Following a Single Dose, from 9:30AM ET on Sunday Nov 17, 2024 by Dow Jones

Nov 12, 2024

Alnylam Pharmaceuticals Shares Fall After Wolfe Downgrade, from 2:23PM ET on Tuesday Nov 12, 2024 by MT Newswires

Peers Headlines

Today

DJ Novo Nordisk A/S Stock Rises Friday, Outperforms Market, from 2 hours ago by Dow Jones

Yesterday

DJ The FDA Can't Decide Whether Zepbound Is in Shortage. It's Good News for Hims & Hers. -- Barrons.com, from 21 hours ago by Dow Jones

Prestige Consumer Healthcare Insider Sold Shares Worth $898,241, According to a Recent SEC Filing, from 22 hours ago by MT Newswires

DJ Novo Nordisk A/S Stock Falls Thursday, Underperforms Market, from 12:03PM ET on Thursday Nov 21, 2024 by Dow Jones

European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday, from 11:20AM ET on Thursday Nov 21, 2024 by MT Newswires

DJ Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barrons.com, from 2:00AM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 20, 2024

DJ Novo Nordisk A/S Stock Rises Wednesday, Outperforms Market, from 12:03PM ET on Wednesday Nov 20, 2024 by Dow Jones

Sector Update: Health Care Stocks Edge Higher Premarket Wednesday, from 9:18AM ET on Wednesday Nov 20, 2024 by MT Newswires

John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX® (collagenase clostridium histolyticum), from 8:50AM ET on Wednesday Nov 20, 2024 by CNW Group

John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX(R) (collagenase clostridium histolyticum), from 8:50AM ET on Wednesday Nov 20, 2024 by PR Newswire